SUVENPHAR Suven Pharmaceuticals Ltd Company Mergers Announcement 2024 - Acquisition Update Suven Pharmaceuticals has acquired 56% of NJ Bio, Inc. for USD 64.4 million, including a USD 15 million equity infusion, completed on December 20, 2024..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Suven Pharmaceuticals Ltd